The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Amlotan 10 mg tablet



Athlone Pharmaceuticals LimitedPA1418/003/002

Main Information

Trade NameAmlotan 10 mg tablet
Active SubstancesAmlodipine
Dosage FormTablet
Licence HolderAthlone Pharmaceuticals Limited
Licence NumberPA1418/003/002

Group Information

ATC CodeC08CA Dihydropyridine derivatives
C08CA01 amlodipine

Status

License statusAuthorised
Licence Issued18/08/2006
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0045-002-008
Interchangeable List DocumentPDF of Interchangeable List
« Back